2041 Dynamic Screening Nutritional Risk Index on Treatment Tolerance and Hospitalization Costs in Cancer Patient: A 3-Year Longitudinal Cohort Study Hongfan Yu 1 , Li Tang 2 , Qiuling Shi 1 , Xing Wei 3 1 State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing, China, 2 Shaoxing Second Hospital, Shaoxing, China, 3 Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of the University of Electronic Science and Technology of China, Chengdu, China Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :2041 Aims Assessment of the advanced cancer patient developing malnutrition has been limited to cross-sectional design
doi: 10.2217/fon-2022-0165 66 de VriesLHLodewijkLVerversTPootAJvan RooijRBrosensLAAet al
Elkis Y, Bel S, Lerer-Goldstein T, Nyska A, Creasy DM, Shpungin S, et al
Does oral semaglutide impact thyroid, pancreatic, or renal health monitoring
The clinical importance of that change remains unproven without PEG-MGF-specific human pharmacokinetic studies [13] [14]
Effect of thioltransferase (glutaredoxin) deletion on cellular sensitivity to oxidative stress and cell proliferation in lens epithelial cells of thioltransferase knockout mouse